Kyowa Kirin Australia
Kyowa Kirin strives to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Since 2000, Kyowa Kirin carved and established a niche in certain parts of Asia Pacific with a focus on providing effective patient care therapies in haematology.
For more than a decade, Kyowa Kirin has invested our efforts towards leveraging innovation and technological advancements to further enhance patient experience and the patient value across therapeutic areas that are less approached.
To bring these advances to Australians we established Kyowa Kirin Australia in 2019. Our Australian operation is headquartered in the Sydney CBD.
Aspiring for a patient-care journey through our cutting-edge technology
Driven by state-of-the-art antibody technologies and hematopoietic stem cell gene therapy, our global business is focused on bone & mineral, intractable hematological diseases/hemato oncology, rare diseases.
In this way, the company is working to realise a vision of becoming a Japan-based global specialty pharmaceutical company that contributes to the health and well-being of people around the world.
You can learn more about our global business at www.kyowakirin.com.
Our Philosophy
Kyowa Kirin aspires to collaborate with our counterparts to contribute to the health and well-being of people around the world by creating new value through the pursuits of advances in science and technologies.
